Indian Journal of Ophthalmology - Case Reports

OPHTHALMIC IMAGE
Year
: 2021  |  Volume : 1  |  Issue : 4  |  Page : 873-

Resolution of angle new vessel


Premanand Chandran, Anu F Anand, Ganesh V Raman 
 Glaucoma Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India

Correspondence Address:
Dr. Premanand Chandran
Aravind Eye Hospital, Avinashi Road, Coimbatore - 641 014, Tamil Nadu
India




How to cite this article:
Chandran P, Anand AF, Raman GV. Resolution of angle new vessel.Indian J Ophthalmol Case Rep 2021;1:873-873


How to cite this URL:
Chandran P, Anand AF, Raman GV. Resolution of angle new vessel. Indian J Ophthalmol Case Rep [serial online] 2021 [cited 2021 Nov 27 ];1:873-873
Available from: https://www.ijoreports.in/text.asp?2021/1/4/873/327741


Full Text



A 64-year-old gentleman presented with visual acuity of 20/40 in the right eye (RE) and 20/20 in the left eye (LE). Slit-lamp examination showed neovascularization of iris in both eyes with an intraocular pressure (IOP) of 32 and 16 mmHg in the RE and LE, respectively. Gonioscopy showed open angles in both eyes with neovascularization of the angle in the RE [Figure 1]a. Fundus examination showed hemorrhage and new vessels in the retina, suggestive of proliferative diabetic retinopathy. He underwent intravitreal injection of ranibizumab and panretinal photocoagulation. At the final follow-up, IOP was 16 mmHg on two antiglaucoma medications with the resolution of angle new vessels in the RE [Figure 1]b. Early detection and prompt treatment for angle new vessel will prevent synechiae formation and refractory glaucoma.[1],[2]{Figure 1}

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008;28:696-702.
2Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-6.